New innovations in cervical cancer screening

Clinical Obstetrics and Gynecology

Volumn 44, Issue 3, 2001, Pages 538-549

  Cohn, David E ^a   Herzog, Thomas J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CYTODIAGNOSIS; CANCER SCREENING; COMPUTER ASSISTED DIAGNOSIS; CONFERENCE PAPER; FLUORESCENCE SPECTROSCOPY; HUMAN; INTERMETHOD COMPARISON; PAPANICOLAOU TEST; UTERINE CERVIX CANCER; VIRUS DETECTION; WART VIRUS;

COLPOSCOPES; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; SPECTROMETRY, FLUORESCENCE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034892833     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200109000-00009     Document Type: Conference Paper

References (29)

1. Cancer Statistics 2001
2. Cervical cancer
3. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan
4. Evaluation of cervical cytology
5. Meta-analysis of Pap test accuracy
6. Evaluation of the ThinPrep Pap test as an adjunct to the conventional Papanicolaou test
7. Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening
8. Multisite clinical outcome trial to evaluate performance of the ThinPrep Pap test
9. Evaluation of the ThinPrep Pap test in clinical practice. A seven-month, 16,314-case experience in northern Vermont
10. Biopsy-based comparison of liquid-based, thin-layer preparations to conventional Papanicolaou tests
11. Performance of a fluid-based, thin-layer Papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England
12. Utility of liquid-based cytology for cervical carcinoma screening. Results of a population-based study conducted in region of Costa Rica with a high incidence of cervical carcinoma
13. Cost-effectiveness of 3 methods to enhance the sensitivity of Papanicolaou testing
14. Setting the target for a better cervical cancer screening test: Characteristics of a cost-effective test for cervical neoplasia screening
15. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing
16. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
17. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions
18. Persistence of type-specific human papillomavirus infection among cytologically normal women
19. HPV DNA testing in cervical cancer screening. Results from women in a high-risk province in Costa Rica
20. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer
21. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial
22. Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results
23. Human papillomavirus testing in women with mild cytologic atypical
24. Performance of a semiautomated Papanicolaou smear screening system. Results of a population-based study conducted in Guanacaste, Costa Rica
25. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap system. Results of a primary screening clinical trial
26. Assessment of automated primary screening on PAPNET of cervical smears in the PRISMATIC trial
27. PAPNET-assisted rescreening of cervical smears: Cost and accuracy compared with a 100% manual rescreening strategy
28. In vivo diagnosis of cervical intraepithelial neoplasia using 337-nm excited laser-induced fluorescence
29. Screening for squamous intraepithelial lesions with fluorescence spectroscopy